‘The 2020 IOL Market Report’ provides an in-depth analysis of the 2020 market and future impact of the COVID-19 pandemic by country/ region of the world. For comparison, all forecast tables and figures will show our original 2020 forecast prior to the existence of the coronavirus alongside the latest 2020 forecast. The new report forecasts 11 different IOL categories: commodity, enhanced and intermediate optimized monofocal, bifocal, trifocal, EDOF, EDOF/MF, accommodating, toric, post-op adjustable, and phakic.
‘The 2020 IOL Market Report’ provides an in-depth analysis of the 2020 intraocular lens market and future impact of the COVID-19 pandemic by country/region of the world. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success. The analysis focuses on the 2020 market and forecasts market growth and evolution through 2025.
Coverage also includes:
- Information on cataract incidence and cataract surgeries worldwide.
- Current estimates and five-year forecasts for global cataract surgery volume.
- Forecasts for adoption of simultaneous bilateral cataract surgery.
- Discussion of presbyopia, refractive errors, and refractive lens exchange procedures.
- Forecasts for sales of five types of presbyopia-correcting IOLs (PC-IOLs) by country/region.
- Forecasts for sales of standard and toric versions of PC-IOLs.
- Forecasts for monovision and mini-monovision by country/region.
- Profiles of cataract and cataract/refractive surgeons in the US.
- Information on corporate surgery providers.
- Discussion of current reimbursement levels.
Given the uncertainties surrounding when cataract surgery will fully resume following the COVID-19 lockdown in each country, we will be providing a reforecast in late July 2020, including revised forecast tables and figures, to clients who purchase the report.
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house analysts with over 100 years of collective ophthalmic market research experience. Each data point is driven by a combination of sources, including:
- Our proprietary global disease population and demographic models
- Analysis of company-published financial reports
- Focused coverage of ophthalmic scientific research, business news, and other activities
- Attendance and participation in worldwide ophthalmic meetings
- Interviews and relationships with company executives and practicing physicians